A phase I clinical trial combining dendritic cell vaccination with adoptive T cell transfer in patients with stage IV melanoma
Crossref DOI link: https://doi.org/10.1007/s00262-014-1575-2
Published Online: 2014-07-04
Published Print: 2014-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Poschke, Isabel
Lövgren, Tanja
Adamson, Lars
Nyström, Maria
Andersson, Emilia
Hansson, Johan
Tell, Roger
Masucci, Giuseppe V.
Kiessling, Rolf
Text and Data Mining valid from 2014-07-04